KENILWORTH, N.J., Feb. 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced with sadness today the death of former executive Steven C. Chellevold, 56, following a long battle with cancer. Prior to his retirement last July, Chellevold served as chairman, Global Supply Chain Operations, Schering-Plough Corporation.
"Steve was a valuable member of our senior management team. He brought strong leadership and strategic vision to the many employees who were fortunate enough to work with him over his long career with the company," said Fred Hassan, chairman and chief executive officer. "Steve built trust inside and outside of the organization. He was a person of great courage. On behalf of all Schering-Plough colleagues worldwide, we would like to extend our condolences to the Chellevold family."
Chellevold joined Schering-Plough's animal health business in 1970 and subsequently held positions of increasing responsibility, becoming manager, manufacturing, in 1982. In 1983, he was appointed manager of strategic planning, interferon production, for Schering-Plough's U.S. prescription pharmaceutical business, and in 1984 he rejoined Schering-Plough's animal health business as senior director, technical operations. Chellevold became executive director, biotechnology, in 1990 and senior director, New Jersey production operations, in 1991. He was appointed general manager of Schering- Plough (Pty.) Ltd., South Africa, in 1995 and a regional sales director of the company's Key Pharmaceuticals business in 1996. In 1998, he became vice president, worldwide technical operations, for Schering-Plough's animal health business, and in 2000 he was appointed senior vice president, technical operations. He assumed the role of chairman, Global Supply Chain Operations, in Oct. 2003.
Chellevold was a graduate of Edgewood College, Madison, Wis.
Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 30,000 people around the world.
The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com/.
CONTACT: Media, Rosemarie Yancosek, +1-908-298-7476, or Investors, AlexKelly, +1-908-298-7450, or Janet M. Barth, +1-908-298-7417, all of Schering-Plough